Entries by Reuters Health

, ,

Teva shares slide on generic Copaxone fears

(Reuters) – Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva’s Tel Aviv shares fell to 249.80 shekels ($64) late on Sunday, the first day of trading since both news […]

Hearing aids may slow cognitive decline tied to hearing loss

Hearing aids may lessen the forgetfulness and mental confusion tied to moderate to severe hearing loss, suggests a new study. “This study is important because it focuses on a risk factor that is amenable to intervention in later life and could potentially postpone cognitive decline,” said Jennifer Deal, the study’s lead author from the Bloomberg […]

FDA approves AcuFocus’ corneal implant

The U.S. Food and Drug Administration approved AcuFocus Inc’s corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. Presbyopia is a condition associated […]

,

Household bleach may raise children’s infection risk

At home and at school, cleaning with chlorine bleach is meant to kill germs that could make kids sick, but a large European study finds bleach may be having the opposite effect. Children in The Netherlands, Finland and Spain who were regularly exposed to bleach-cleaned environments had higher rates of respiratory-tract infections, including influenza, bronchitis and […]

ReNeuron stem cell therapy shows long-term promise for stroke

A pioneering stem cell treatment for patients disabled by stroke has continued to show long-term promise in a clinical trial, the British biotech company behind the project said on Friday. News that two-year follow-up data from a small Phase I study showed improvements in limb function with no worrying safety issues lifted shares in ReNeuron […]